Fundus Photography and Fluorescein Angiography

A retinal detachment missed on clinical exam, a microaneurysm too small to see through a handheld ophthalmoscope, a slow leak in the choroidal vasculature that only reveals itself under fluorescent light — these are the diagnostic gaps that fundus photography and fluorescein angiography were built to close. Together, these two imaging modalities form the backbone of retinal diagnostics, used in conditions ranging from diabetic retinopathy (which affects approximately 9.6 million Americans, per the CDC) to age-related macular degeneration and retinal vein occlusion. One captures the anatomy. The other maps the physiology. Understanding both — and how they differ — matters for anyone trying to make sense of a retinal workup.

Fundus Photography: The Anatomical Snapshot

Fundus photography produces a high-resolution, color image of the posterior segment of the eye, including the optic disc, macula, fovea, and retinal vasculature. The technique relies on a specialized low-power microscope fitted with a flash-enabled camera. The patient's pupil is typically dilated with tropicamide or phenylephrine to allow a wider field of view, though non-mydriatic cameras capable of imaging through a pupil as small as 3.5 mm have become standard in screening settings.

The standard field of view for traditional fundus cameras covers approximately 30 to 50 degrees of the retina. Ultra-widefield systems — such as the Optos platform — can capture up to 200 degrees in a single image, covering roughly 82% of the retinal surface (National Eye Institute). This expanded view has proven particularly valuable in detecting peripheral retinal pathology in diabetic eye disease, where lesions outside the standard seven-field Early Treatment Diabetic Retinopathy Study (ETDRS) protocol can change clinical staging.

Fundus photographs serve three key purposes:

• Baseline documentation — establishing a reference point against which future changes can be measured.
• Screening — particularly in telemedicine programs for diabetic retinopathy, where images are captured at primary care sites and read remotely by trained graders or artificial intelligence algorithms.
• Patient education — a photograph of hemorrhages, exudates, or drusen can communicate disease severity more effectively than any verbal explanation.

The Indian Health Service's teleophthalmology program, for example, uses fundus photography to screen diabetic patients in remote tribal communities, transmitting images to reading centers for grading (IHS).

Fluorescein Angiography: The Dynamic Map

Where fundus photography captures structure, fluorescein angiography (FA) captures function — specifically, the behavior of blood flow through the retinal and choroidal vasculature. The procedure involves injecting sodium fluorescein dye (typically 5 mL of a 10% solution) into an antecubital vein. As the dye circulates through the ocular vasculature, a fundus camera equipped with excitation (465–490 nm) and barrier (520–530 nm) filters captures a rapid sequence of images over approximately 10 minutes.

The resulting angiogram unfolds in distinct phases:

1. Choroidal phase (~9–15 seconds after injection) — dye fills the choroidal vasculature, producing a patchy background fluorescence.
2. Arterial phase — retinal arteries fill.
3. Arteriovenous phase — veins begin to show laminar flow.
4. Venous phase — complete filling of the retinal veins.
5. Late phase (~5–10 minutes) — dye normally clears; persistent or new fluorescence indicates pathology.

The diagnostic power of FA lies in identifying two fundamental abnormalities: hyperfluorescence (excess fluorescence caused by leakage, pooling, staining, or window defects) and hypofluorescence (reduced fluorescence caused by blockage or vascular non-perfusion). A classic example: in diabetic macular edema, petaloid hyperfluorescence in the late phase reveals cystoid fluid accumulation in the outer plexiform layer — a finding that directly informs treatment decisions regarding anti-VEGF injections or laser photocoagulation.

Safety Profile and Adverse Reactions

Fluorescein angiography is considered a safe procedure, but it is not risk-free. The most common side effects are transient nausea (reported in roughly 2.9% of patients) and yellow discoloration of the skin and urine for 24–36 hours — a fact that should be mentioned beforehand, if only to prevent alarmed phone calls. Mild urticaria occurs in about 1% of cases. Severe anaphylactic reactions are rare, estimated at approximately 1 in 220,000 injections, according to data reviewed in the American Academy of Ophthalmology Preferred Practice Patterns (AAO). The dye is relatively contraindicated in pregnancy due to its ability to cross the placenta, though no teratogenic effects have been conclusively demonstrated in humans.

When Each Test Is Appropriate

Fundus photography alone suffices for screening, documentation, and monitoring of conditions with visible structural changes — drusen in macular degeneration, for instance, or optic disc edema. Fluorescein angiography becomes necessary when the clinical question involves vascular integrity: Is there neovascularization? Where exactly is the leakage? How extensive is the capillary non-perfusion?

In practice, the two are often performed sequentially. A fundus photograph establishes the anatomical context; the angiogram then adds the hemodynamic story. Optical coherence tomography (OCT) has replaced FA for some applications — particularly measuring macular thickness in edema — but FA remains irreplaceable for mapping perfusion deficits and guiding targeted laser therapy. The National Eye Institute continues to reference FA as a standard diagnostic tool in the evaluation of diabetic retinopathy and its complications.

Frequently Asked Questions

How long does a fluorescein angiography procedure take?

The injection itself takes seconds, and the imaging sequence runs approximately 10 minutes. Including preparation, dilation, and post-procedure observation, the entire visit typically spans 30 to 45 minutes.

Does fluorescein angiography hurt?

The primary discomfort is the intravenous needle stick. The dye injection may produce brief warmth or mild nausea, but the imaging process — which uses only light — is painless.

Can fundus photography detect glaucoma?

Fundus photography can document optic disc cupping, rim thinning, and nerve fiber layer hemorrhages associated with glaucoma. However, it does not measure intraocular pressure or visual field loss, so it functions as one component of a broader glaucoma evaluation.

Is fluorescein the same as indocyanine green angiography?

No. Indocyanine green (ICG) angiography uses a different dye with near-infrared fluorescence properties, allowing better visualization of the choroidal vasculature beneath the retinal pigment epithelium. ICG is preferred for conditions like polypoidal choroidal vasculopathy and central serous chorioretinopathy.

References

• Centers for Disease Control and Prevention — Diabetes Data and Statistics
• National Eye Institute — Diabetic Retinopathy
• American Academy of Ophthalmology — Preferred Practice Patterns
• Indian Health Service — Joslin Vision Network Teleophthalmology Program
• National Eye Institute — Eye Health Information

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)